AstraZeneca
|
|
🇬🇧 Cambridgeshire, England, Cambridge+10
|
$ >1000M |
1987 |
2,201,448 |
Biotechnology, Health Care |
AbD Serotec – a Bio-Rad Company
|
|
🇬🇧 Oxfordshire, England, Cherwell District+4
|
$ 500-1000M |
1952 |
308,265 |
Biotechnology, Life Science |
R&D Systems
|
|
🇬🇧 Abingdon+21
|
$ 500-1000M |
1985 |
752,607 |
Biotechnology, Life Science |
The Francis Crick Institute
|
|
🇬🇧 London Borough Of Camden, England, London+5
|
$ 500-1000M |
2011 |
449,668 |
Biotechnology, Health Care |
The Institute of Cancer Research, London
|
|
🇬🇧 Royal Borough Of Kensington And Chelsea, England, London+6
|
$ 100-500M |
1909 |
362,551 |
Biotechnology, Clinical Trials |
Impc
|
|
🇬🇧 Cambridgeshire, England, South Cambridgeshire+1
|
$ 100-500M |
2011 |
102,960 |
Biotechnology, Genetics |
Ergomed
|
|
🇬🇧 Surrey, England, Guildford+67
|
$ 100-500M |
1997 |
36,651 |
Clinical Trials, Health Care |
Cancer Grand Challenges
|
|
🇬🇧 England, London+5
|
$ 100-500M |
2020 |
17,658 |
Health Care, Life Science |
Quotient Sciences
|
|
🇬🇧 Nottingham, England, Nottingham+10
|
$ 100-500M |
2004 |
25,092 |
Biotechnology, Pharmaceutical |
Nature Publishing Group
|
|
🇬🇧 England, London+19
|
$ 100-500M |
1869 |
71,153,999 |
Biotechnology, Life Science |
AstraZeneca
|
|
🇬🇧 Cambridgeshire, England, Cambridge+10
|
$ >1000M |
1987 |
2,201,448 |
Biotechnology, Health Care |
AbD Serotec – a Bio-Rad Company
|
|
🇬🇧 Oxfordshire, England, Cherwell District+4
|
$ 500-1000M |
1952 |
308,265 |
Biotechnology, Life Science |
R&D Systems
|
|
🇬🇧 Abingdon+21
|
$ 500-1000M |
1985 |
752,607 |
Biotechnology, Life Science |
The Francis Crick Institute
|
|
🇬🇧 London Borough Of Camden, England, London+5
|
$ 500-1000M |
2011 |
449,668 |
Biotechnology, Health Care |
The Institute of Cancer Research, London
|
|
🇬🇧 Royal Borough Of Kensington And Chelsea, England, London+6
|
$ 100-500M |
1909 |
362,551 |
Biotechnology, Clinical Trials |
Impc
|
|
🇬🇧 Cambridgeshire, England, South Cambridgeshire+1
|
$ 100-500M |
2011 |
102,960 |
Biotechnology, Genetics |
Ergomed
|
|
🇬🇧 Surrey, England, Guildford+67
|
$ 100-500M |
1997 |
36,651 |
Clinical Trials, Health Care |
Cancer Grand Challenges
|
|
🇬🇧 England, London+5
|
$ 100-500M |
2020 |
17,658 |
Health Care, Life Science |
Quotient Sciences
|
|
🇬🇧 Nottingham, England, Nottingham+10
|
$ 100-500M |
2004 |
25,092 |
Biotechnology, Pharmaceutical |
Nature Publishing Group
|
|
🇬🇧 England, London+19
|
$ 100-500M |
1869 |
71,153,999 |
Biotechnology, Life Science |